CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence. Mod Pathol. 2017 07; 30(7):1032-1041.

View in: PubMed

subject areas

Aged
beta Catenin
Carcinoma, Endometrioid
Disease-Free Survival
DNA Mutational Analysis
Endometrial Neoplasms
Female
Humans
Middle Aged
Mutation
Neoplasm Grading
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Retrospective Studies
Risk Factors
Tumor Suppressor Protein p53

authors with profiles

Katherine Kurnit